Regulatory Relief
The regulatory burden faced by hospitals is substantial and unsustainable.
Every day, hospitals, health systems and post-acute care providers confront the daunting task of complying with a growing number of federal regulations. They are constantly challenged to understand and implement new or revised regulations, while maintaining their core mission of providing high-quality patient care.
Providers appreciate that federal regulation is intended to ensure that health care patients receive safe, high-quality care, and prioritize it as a critical part of their day-to-day work.
But the scope and pace of the changes being made is out-stripping many providers’ ability to absorb them. At the same time, many of these regulations do not improve the quality of patient care or access to services.
Providers need relief now. Read on for more information and resources on the AHA's regulatory relief agenda.
The AHA May 12 responded to the Office of Management and Budget's April 11 request for information on regulatory relief, making 100 suggestions to the Trump administration to help reduce burden on hospitals and health systems.
AHA responds to the Office of Management and Budget Deregulation Request for Information.
The Trump administration May 5 issued two executive orders on pharmaceutical manufacturing and life-sciences research.
The Centers for Medicare & Medicaid Services today released a notice seeking public comment on the collection of information request regarding the State Plan Amendment template for medication-assisted treatment. SPA templates are provided by CMS to assist states with Medicaid application…
The Trump administration April 9 released a series of executive orders (EOs) and took other administrative actions aimed at reducing regulatory burden.
Our shared focus with Congress and Administration is on providing relief from the pandemic, ensuring a smooth recovery, and rebuilding a better health care system for the future. The American Hospital Association continues to incorporate principles that promote improved affordability, value, and…
The AHA provides comments before the Senate Committee on Budget on ways to reduce administrative burden and costs in the health care system.
AHA addresses UnitedHealthcare’s implementation of its Molecular Pathology Reimbursement Policy on April 1, 2024.
The AHA supports policies and legislation that enable rural hospitals to care for their communities. The Rural Advocacy Agenda outlines some key areas of focus for our 2024 advocacy agenda.
Waivers allowed practitioners to render telehealth services from their home without having to report their home address on Medicare enrollment or claims forms. Beginning Jan. 1, 2024, these providers will be required to report their home address on enrollment and claims forms.